Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab After Induction Treatment in TNBC (TONIC)
NCT02499367Phase 2Unknown
- Sponsor
- Netherlands Cancer Institute
- Start
- Aug 2015
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in triple negative breast cancer (TNBC), sponsored by Netherlands Cancer Institute. Status: unknown.
02
Drugs
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02499367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499367.